Yes, circRNAs hold promise as biomarkers for cancer diagnosis and prognosis due to their stability, abundance, and specific expression patterns in cancerous tissues. For example, circRNA CDR1as is known to be highly expressed in certain types of cancer and can serve as a potential diagnostic marker. Additionally, the unique expression profiles of circRNAs in different cancer types can help in the classification of tumors and in predicting patient outcomes.
